June 24, 2025

Exam Shift Spurs National Rights Battle

Democratic AGs push to relocate OB-GYN exams from Texas, citing threats to reproductive and gender-affirming care under state abortion bans.

KFF Health News

June 23, 2025

Fidaxomicin Effective, Well-Tolerated in Pediatric CDI

A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.

Conexiant

June 20, 2025

FDA Approves First Twice-Yearly Injectable PrEP

FDA approved the first biannual injectable PrEP option, Yeztugo (lenacapavir), after studies showed it prevented HIV infection in over 99.9% of participants.

Conexiant

June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant

June 16, 2025

Updated Guidance on Antirheumatic Drug Use

New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.

Conexiant

June 12, 2025

Interleukin-6 in the Fight Against Sepsis

Biomarker shows diagnostic potential in a real-world setting

The Pathologist

June 11, 2025

8-Week Oral Therapy Approved for Acute HCV

The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention.

Conexiant

June 09, 2025

New Fixed-Dose RSV Antibody Approved

The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.

Conexiant

June 05, 2025

Risky College Behaviors Harming Oral Health?

First-year university students who adopted unhealthy habits such as poor diet, vaping, and reduced brushing frequency experienced significant declines in self-reported oral health over 6 months.

Conexiant